Hypothermic Storage of Human Hepatocytes for Transplantation
Open Access
- 1 September 2014
- journal article
- Published by SAGE Publications in Cell Transplantation
- Vol. 23 (9) , 1143-1151
Abstract
Transplantation of human hepatocytes is gaining recognition as a bridge or an alternative to orthotopic liver transplantation for patients with acute liver failure and genetic defects. Since most patients require multiple cell infusions over an extended period of time, we investigated hepatic functions in cells maintained in University of Wisconsin solution at 4°C up to 72 h. Eleven different assessments of hepatic viability and function were investigated both pre- and posthypothermic storage, including plating efficiency, caspase-3/7 activity, ammonia metabolism, and drug-metabolizing capacity of isolated hepatocytes. Long-term function, basal, and induced cytochrome P450 activities were measured after exposure to prototypical inducing agents. Cells from 47 different human liver specimens were analyzed. Viability significantly decreased in cells cold stored in UW solution, while apoptosis level and plating efficiency were not significantly different from fresh cells. Luminescent and fluorescent methods assessed phases I and II activities both pre- and post-24-72 h of cold preservation. A robust induction (up to 200-fold) of phase I enzymes was observed in cultured cells. Phase II and ammonia metabolism remained stable during hypothermic storage, although the inductive effect of culture on each metabolic activity was eventually lost. Using techniques that characterize 11 measurements of hepatic viability and function from plating efficiency, to ammonia metabolism, to phases I and II drug metabolism, it was determined that while viability decreased, the remaining viable cells in cold-stored suspensions retained critical hepatic functions for up to 48 h at levels not significantly different from those observed in freshly isolated cells.Keywords
This publication has 29 references indexed in Scilit:
- Human hepatocyte transplantation: current experience and future challengesNature Reviews Gastroenterology & Hepatology, 2010
- Iron chelation or anti-oxidants prevent renal cell damage in the rewarming phase after normoxic, but not hypoxic cold incubationCryobiology, 2007
- Human Hepatocyte Transplantation: Worldwide ResultsTransplantation, 2006
- Hepatocyte transplantation for liver‐based metabolic disordersJournal of Inherited Metabolic Disease, 2006
- Portal vein thrombosis after intraportal hepatocytes transplantation in a liver transplant recipientTransplant International, 2005
- Optimization of Conditions for Clinical Human Hepatocyte InfusionCell Transplantation, 2004
- Hypothermia Inhibits Fas-Mediated Apoptosis of Primary Mouse Hepatocytes in CultureCell Transplantation, 2004
- Induction of Necrosis and DNA Fragmentation during Hypothermic Preservation of Hepatocytes in UW, HTK, and Celsior SolutionsCell Transplantation, 2003
- Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte TransplantationNew England Journal of Medicine, 1998
- PRINCIPLES OF SOLID-ORGAN PRESERVATION BY COLD STORAGETransplantation, 1988